Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab

Mayara Elisa Bonatto, Jan Dvořák, Marek Kollár, David Girsa, Miroslav Průcha, Šárka Forejtová, Heřman Mann, Jiří Vencovský, Karel Pavelka, Ladislav Šenolt

Open source

DOI
10.3389/fimmu.2026.1884821
Published
2026-07-15
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1884821,
  title = {Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab},
  author = {Mayara Elisa Bonatto and Jan Dvořák and Marek Kollár and David Girsa and Miroslav Průcha and Šárka Forejtová and Heřman Mann and Jiří Vencovský and Karel Pavelka and Ladislav Šenolt},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1884821},
  url = {https://doi.org/10.3389/fimmu.2026.1884821}
}

RIS

TY  - JOUR
TI  - Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab
AU  - Mayara Elisa Bonatto
AU  - Jan Dvořák
AU  - Marek Kollár
AU  - David Girsa
AU  - Miroslav Průcha
AU  - Šárka Forejtová
AU  - Heřman Mann
AU  - Jiří Vencovský
AU  - Karel Pavelka
AU  - Ladislav Šenolt
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1884821
UR  - https://doi.org/10.3389/fimmu.2026.1884821
ER  - 

APA

Bonatto, M. E., Dvořák, J., Kollár, M., Girsa, D., Průcha, M., Forejtová, Š., Mann, H., Vencovský, J., Pavelka, K., & Šenolt, L. (2026). Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1884821

Source records